NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $125 | -98.0% | 3 | -97.1% | 0.00% | – |
| Q1 2023 | $6,315 | -57.0% | 105 | -47.5% | 0.00% | – |
| Q4 2022 | $14,670 | -2.2% | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $15,000 | +275.0% | 200 | +227.9% | 0.00% | – |
| Q2 2022 | $4,000 | – | 61 | +6000.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 1 | -95.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 20 | +42.9% | 0.00% | – |
| Q3 2021 | $2,000 | -93.8% | 14 | -90.3% | 0.00% | – |
| Q2 2021 | $32,000 | +3100.0% | 145 | +866.7% | 0.00% | – |
| Q1 2020 | $1,000 | – | 15 | +400.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 3 | -98.8% | 0.00% | – |
| Q1 2016 | $4,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |